IMMUNOTERAPIYANING ZAMONAVIY ONKOLOGIYADA O‘RNI
Keywords:
Kalit so‘zlar: immunoterapiya, onkologiya, immun tizimi, saraton, immun chekpoint inhibitorlariAbstract
Annotatsiya: Onkologik kasalliklar dunyo bo‘ylab o‘limning yetakchi sababi
bo‘lib qolmoqda. So‘nggi yillarda saratonni davolashda an’anaviy usullar (jarrohlik,
kimyo va nurlanish terapiyasi) bilan bir qatorda, immunoterapiya jadal sur’atlar bilan
rivojlanmoqda. Ushbu maqolada immunoterapiya turlari, ta’sir mexanizmi, klinik
qo‘llanilishi va afzalliklari haqida zamonaviy ilmiy manbalar asosida tahlil berilgan.
References
Foydalanilgan adabiyotlar
1. Couzin-Frankel J. Cancer immunotherapy. Science. 2013.
2. Mellman I et al. Cancer immunotherapy comes of age. Nature. 2011.
3. Slamon DJ et al. Use of trastuzumab for the treatment of HER2-positive breast
cancer. NEJM. 2001.
4. Postow MA et al. Immune checkpoint blockade in cancer therapy. J Clin Oncol.
2015.
5. Maude SL et al. Chimeric antigen receptor T cells for leukemia. NEJM. 2014.
6. Kantoff PW et al. Sipuleucel-T immunotherapy for prostate cancer. NEJM.
2010.
7. Borghaei H et al. Nivolumab vs Docetaxel in advanced NSCLC. NEJM. 2015.
8. Larkin J et al. Combined nivolumab and ipilimumab in melanoma. NEJM. 2015.
9. Wang DY et al. Immune-related adverse events of checkpoint inhibitors. JAMA
Oncol. 2018.
10. Topalian SL et al. Biomarkers for immunotherapy. Nat Rev Cancer. 2016.
